In mice and in humans, treatment with the second-generation antipsychotic drug olanzapine (OLZ) produces excessive weight gain, adiposity and secondary metabolic complications, including loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback